Subsequent Events |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Subsequent Events | |
| Subsequent Events | 16.Subsequent Events Convertible Senior Notes and Follow-on Public Equity Offering In April 2026, the underwriters of the Company’s offering of the Convertible Notes and follow-on public equity offering exercised their overallotment option in full, pursuant to which the Company received aggregate principal amount of $30.0 million, before deducting commission costs of $0.9 million for the Convertible Notes and issued 750,000 shares of common stock, at $20.00 per share, for gross proceeds of $15.0 million before deducting commission costs of $0.9 million for the follow-on public equity offering. ZB021 Milestone On May 13, 2026, the Company announced the achievement of the Regulatory Milestone for ZB021 under the InnoCare License Agreement and is required to pay InnoCare $20.0 million related to this event. |